What neonatal assessment and care are indicated for an infant whose mother had preeclampsia only during pregnancy?

Neonatal Assessment and Care for Infants Born to Mothers with Preeclampsia

Infants born to mothers with preeclampsia require comprehensive assessment for complications including fetal growth restriction, prematurity-related morbidities, and specific neonatal conditions, with the intensity of monitoring determined primarily by gestational age at delivery and presence of growth restriction.

Risk Stratification Based on Maternal Disease

The severity and timing of maternal preeclampsia directly impacts neonatal outcomes. Preeclampsia is strongly associated with fetal growth restriction, low birth weight, preterm delivery, respiratory distress syndrome, and admission to neonatal intensive care 1. Early-onset preeclampsia (before 34 weeks) carries substantially higher neonatal risk than late-onset disease 2.

Key Neonatal Risk Factors to Assess:

• Gestational age at delivery: The most critical determinant of neonatal outcome
• Presence of fetal growth restriction (FGR): Occurs in 43% of preeclamptic pregnancies versus 8% in gestational hypertension alone 3
• Timing of preeclampsia onset: Early-onset (<34 weeks) versus late-onset (≥34 weeks)

Initial Neonatal Assessment

Immediate Evaluation (Delivery Room):

• Apgar scoring at 1,5, and 10 minutes
• Birth weight, length, and head circumference with plotting on growth curves to identify small-for-gestational-age (SGA) status
• Gestational age assessment to confirm dating
• Physical examination for signs of prematurity or growth restriction

Laboratory Assessment:

Complete blood count with differential is essential, as:

• Neutropenia occurs significantly more frequently in infants from early-onset preeclampsia, even when born after 34 weeks 4
• Thrombocytopenia may occur but is not consistently reduced 3
• Leukocyte counts typically remain normal 3

Monitoring Based on Gestational Age

Infants Born <34 Weeks:

These infants require tertiary-level neonatal intensive care with multidisciplinary management 5. Monitor for:

• Respiratory distress syndrome (RDS): Universal screening with respiratory assessment
• Patent ductus arteriosus (PDA): Echocardiographic evaluation if clinically indicated
• Intraventricular hemorrhage (IVH): Cranial ultrasound screening per unit protocol (typically day 7-10 and 28-30)
• Necrotizing enterocolitis (NEC): Clinical monitoring with feeding advancement protocols
• Retinopathy of prematurity (ROP): Ophthalmologic screening per established guidelines
• Bronchopulmonary dysplasia (BPD): Ongoing respiratory assessment

The sFlt-1/PlGF ratio >204 in maternal blood predicts increased risk of these adverse neonatal outcomes 6, though this is primarily a research tool rather than standard clinical practice.

Infants Born 34-37 Weeks:

• Respiratory monitoring for transient tachypnea and RDS (lower risk than <34 weeks)
• Blood glucose monitoring for hypoglycemia, particularly if growth restricted
• Temperature regulation assessment
• Feeding evaluation and weight monitoring
• Jaundice surveillance with bilirubin levels as clinically indicated

Infants Born ≥37 Weeks:

Infants born after 33 completed weeks develop almost no severe neonatal complications 6. However, continue to assess for:

• SGA status: 35% of infants from late-onset preeclampsia may still be growth restricted 4
• Hypoglycemia: Particularly in growth-restricted infants
• Polycythemia: More common in growth-restricted term infants
• Standard newborn screening and assessments

Special Considerations

Growth Restriction:

When FGR is present (AC/EFW <3rd percentile or crossing 50 centiles), the risk increases nine-fold compared to gestational hypertension alone 3. These infants require:

• Enhanced metabolic monitoring: More frequent glucose checks in first 24-48 hours
• Careful feeding advancement: May have feeding intolerance
• Neurodevelopmental follow-up: Long-term surveillance for developmental outcomes

Hospitalization Duration:

Infants born to mothers with high sFlt-1/PlGF ratios (>204) have significantly longer hospitalization times 6. Plan for:

• Extended monitoring periods
• Coordination of subspecialty consultations before discharge
• Comprehensive discharge planning with appropriate follow-up

Common Pitfalls to Avoid:

1. Assuming term infants are low-risk: Even late-onset preeclampsia can result in SGA infants requiring enhanced monitoring
2. Missing neutropenia: This occurs more frequently than expected, particularly in early-onset preeclampsia delivered after 34 weeks 4
3. Inadequate growth assessment: Always plot growth parameters and compare to appropriate references
4. Premature discharge: Infants may appear well initially but develop complications in first 48-72 hours

Discharge Planning:

Before discharge, ensure:

• Stable vital signs for 24 hours minimum
• Adequate feeding with appropriate weight trajectory
• Normal metabolic parameters (glucose, bilirubin)
• Arranged follow-up within 48-72 hours for weight check and clinical assessment
• Neurodevelopmental follow-up scheduled for high-risk infants (preterm, severe FGR)

The intensity of neonatal surveillance should be proportional to gestational age at delivery and presence of growth restriction, with the understanding that appropriate screening and preventive healthcare for preeclampsia can contribute significantly to reducing the incidence of neonatal complications 6.